Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-246.41%
operating margin TTM
-246.78%
revenue TTM
1.42 Million
revenue per share TTM
0.79$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | 1.00 |
| price to sales ratio | 0.77 |
| enterprise value multiple | -0.85 |
| price fair value | 1.00 |
profitability ratios | |
|---|---|
| gross profit margin | 30.44% |
| operating profit margin | -246.78% |
| pretax profit margin | -242.07% |
| net profit margin | -246.41% |
| return on assets | -108.52% |
| return on equity | -72.72% |
| return on capital employed | -143.41% |
liquidity ratios | |
|---|---|
| current ratio | 3.11 |
| quick ratio | 3.11 |
| cash ratio | 2.33 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 29.36 |
| cash conversion cycle | -29.36 |
| receivables turnover | 0.00 |
| payables turnover | 12.43 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.06 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.06 |
| interest coverage | -496.36 |
| cash flow to debt ratio | -21.44 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.22 |
| cash per share | 1.28 |
| operating cash flow per share | -2.22 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -21.44 |
| short term coverage ratios | -23.13 |
| capital expenditure coverage ratio | -949,055.53 |
Frequently Asked Questions
When was the last time InMed Pharmaceuticals Inc. (NASDAQ:INM) reported earnings?
InMed Pharmaceuticals Inc. (INM) published its most recent earnings results on 06-05-2026.
What is InMed Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. InMed Pharmaceuticals Inc. (NASDAQ:INM)'s trailing twelve months ROE is -72.72%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. InMed Pharmaceuticals Inc. (INM) currently has a ROA of -108.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did INM's net profit margin stand at?
INM reported a profit margin of -246.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is INM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.11 in the most recent quarter. The quick ratio stood at 3.11, with a Debt/Eq ratio of 0.06.